Marshall Wace North America’s Edwards Lifesciences EW Stock Holding History

Marshall Wace North America’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-37,927	Closed	-$3.93M	–	1509
2021 Q2	$3.93M	Sell	37,927 -179,186	-83%	-$16.9M	0.02%	620
2021 Q1	$18.2M	Buy	+217,113	New	+$18.4M	0.08%	268
2020 Q1	–	Sell	-201,000	Closed	-$15.6M	–	1342
2019 Q4	$15.6M	Sell	201,000 -948,471	-83%	-$74.1M	0.08%	230
2019 Q3	$84.3M	Buy	1,149,471 +55,995	+5%	+$3.93M	0.48%	61
2019 Q2	$67.3M	Buy	1,093,476 +872,514	+395%	+$52.8M	0.42%	65
2019 Q1	$14.1M	Buy	220,962 +147,270	+200%	+$8.4M	0.1%	175
2018 Q4	$3.76M	Buy	+73,692	New	+$3.73M	0.04%	297
2018 Q3	–	Sell	-5,799	Closed	-$281K	–	1046
2018 Q2	$281K	Sell	5,799 -28,266	-83%	-$1.32M	﹤0.01%	1200
2018 Q1	$1.58M	Sell	34,065 -1,031,802	-97%	-$44.8M	0.01%	868
2017 Q4	$40M	Sell	1,065,867 -48,756	-4%	-$1.79M	0.22%	103
2017 Q3	$40.5M	Sell	1,114,623 -1,535,901	-58%	-$58.6M	0.26%	97
2017 Q2	$104M	Sell	2,650,524 -1,401,369	-35%	-$51.2M	0.76%	19
2017 Q1	$127M	Buy	+4,051,893	New	+$127M	1%	13
2013 Q3	–	Sell	-365,922	Closed	-$4.1M	–	634
2013 Q2	$4.1M	Buy	+365,922	New	+$4.33M	0.32%	108

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Marshall Wace North America's EW Position: Q3 2021 in Review

Marshall Wace North America sold out of Edwards Lifesciences (EW) in Q3 2021, closing a stake of 37,927 shares — an estimated $3.93M sold.

Marshall Wace North America first reported a position in EW in Q2 2013 and held it in 14 quarters. The position peaked at $127M in Q1 2017. 1,229 funds tracked by Wall St. Rank hold EW as of Q3 2021.

Marshall Wace North America reported no remaining Edwards Lifesciences position as of Q3 2021 after selling out during the quarter.
Marshall Wace North America sold 37,927 Edwards Lifesciences shares in Q3 2021, an estimated $3.93M.
Marshall Wace North America first reported a position in Edwards Lifesciences in Q2 2013 and held it in 14 quarters.
Marshall Wace North America's Edwards Lifesciences position peaked at $127M in Q1 2017.
1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.